Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hilgard

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Experientia|January 1, 1970
Increased plasma fibrinogen and the release of a fibrinogen enhancing factor in tumour-bearing ratsP Hilgard, V Hiemeyer
British Journal of Cancer|April 1, 1980
Factor X-activating activity from Lewis lung carcinomaP Hilgard, P Whur
Blut|July 20, 1977
The use of RA 233 in the preparation of platelets, with the blood cell separatorJ H Beyer, P Hilgard
Blut|December 15, 1978
Low-dose heparin in the management of acute myelocytic leukaemiaM R Nowrousian, P Hilgard
European Journal of Cancer|May 1, 1979
Pinocytic activity and CSF production of macrophages during the growth of the Lewis lung carcinoma in miceH Von Melchner, P Hilgard
European Journal of Cancer|October 1, 1976
Anticoagulants in the treatment of cancerP Hilgard, R D Thornes
European Journal of Cancer|November 1, 1978
Transient bleomycin-induced thrombocytopenia. A clinical studyP Hilgard, D K Hossfeld
Progress in Experimental Tumor Research|January 1, 1992
Induction of tumor cell differentiation by alkylphosphocholines: a new approach for in vitro screeningH R Maurer, P Hilgard
Cancer Treatment Reviews|June 1, 1984
alpha-/beta-Triglycidyl-urazol (TGU, NSC 332488, I.N.N.: ANAXIRONE): a new chemotherapeutic agentP Hilgard, M Peukert, J Pohl
Biotechniques|June 1, 1994
Highly sensitive northern hybridization of rare mRNA using a positively charged nylon membraneT Beckers, P Schmidt, P Hilgard
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Experientia|January 1, 1970
Increased plasma fibrinogen and the release of a fibrinogen enhancing factor in tumour-bearing ratsP Hilgard, V Hiemeyer
British Journal of Cancer|April 1, 1980
Factor X-activating activity from Lewis lung carcinomaP Hilgard, P Whur
Blut|July 20, 1977
The use of RA 233 in the preparation of platelets, with the blood cell separatorJ H Beyer, P Hilgard
Blut|December 15, 1978
Low-dose heparin in the management of acute myelocytic leukaemiaM R Nowrousian, P Hilgard
European Journal of Cancer|May 1, 1979
Pinocytic activity and CSF production of macrophages during the growth of the Lewis lung carcinoma in miceH Von Melchner, P Hilgard
European Journal of Cancer|October 1, 1976
Anticoagulants in the treatment of cancerP Hilgard, R D Thornes
European Journal of Cancer|November 1, 1978
Transient bleomycin-induced thrombocytopenia. A clinical studyP Hilgard, D K Hossfeld
Progress in Experimental Tumor Research|January 1, 1992
Induction of tumor cell differentiation by alkylphosphocholines: a new approach for in vitro screeningH R Maurer, P Hilgard
Cancer Treatment Reviews|June 1, 1984
alpha-/beta-Triglycidyl-urazol (TGU, NSC 332488, I.N.N.: ANAXIRONE): a new chemotherapeutic agentP Hilgard, M Peukert, J Pohl
Biotechniques|June 1, 1994
Highly sensitive northern hybridization of rare mRNA using a positively charged nylon membraneT Beckers, P Schmidt, P Hilgard
Pageof 14